Given the strong relationship between inflammation and metabolism, there is mounting evidence suggesting a role for human resistin in the pathological processes of metabolic diseases, including obesity, diabetes, and cardiovascular diseases (Lazar 2007; McTernan et al. 2002). The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.